Kooij Louise Frederika

CIK 00020043791 companyNAARDEN, P7

SEC Profile

Transactions

Companies

Filings

CIK

0002004379

Recent Transactions

37 trades

Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-28$10.90/sh+32,612→ 56,965 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-28$31.80/sh−32,612→ 24,353 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-28−32,612→ 73,134 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-27$32.62/sh−39,816→ 24,353 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-27−39,816→ 105,746 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-27$10.90/sh+39,816→ 64,169 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-26$33.45/sh−309→ 24,353 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-26−34,400→ 145,562 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-26$10.90/sh+34,400→ 58,753 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-26$32.77/sh−34,091→ 24,662 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-23$34.37/sh−12,767→ 24,353 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-23$33.44/sh−25,405→ 37,120 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-23$10.90/sh+38,172→ 62,525 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-23−38,172→ 179,962 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-07+53,500→ 53,500 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-07+12,000→ 24,353 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-05$33.25/sh−2,647→ 12,353 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-09-09$26.11/sh−96,896→ 15,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-09-09$10.00/sh+150,000→ 165,000 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-09-09$25.31/sh−53,104→ 111,896 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-09-09−150,000→ 280,015 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-09-03$25.09/sh−18,073→ 15,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-09-02−18,073→ 0 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-09-02+18,073→ 33,073 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-08-25$24.86/sh−8,269→ 15,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-03-26+8,269→ 8,269 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-26+8,269→ 23,269 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-03-26−8,269→ 0 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-03-04−150,000→ 18,073 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-04$20.37/sh−150,000→ 15,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-04+150,000→ 165,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-07+15,000→ 15,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-02+80,000→ 80,000 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2024-10-01$15.72/sh−45,000→ 0 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2024-09-27+45,000→ 45,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2024-09-27−45,000→ 168,073 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2024-01-01+150,494→ 150,494 total

Companies

NewAmsterdam Pharma Co N.V.
Chief Accounting Officer
$NAMS

Recent Filings

Address

C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35

NAARDEN, P7, 1411 DC

View on SEC.gov